VHH antibodies — commonly known as nanobodies — are the smallest naturally occurring antigen-binding fragments derived from the variable domain of heavy-chain-only antibodies (HCAbs) found in camelids such as alpacas, llamas, and camels. With a molecular weight of only ~15 kDa, nanobodies are approximately 10 times smaller than conventional IgG antibodies, yet they retain full antigen-binding capability with exceptional affinity and specificity.
In the context of ELISA (Enzyme-Linked Immunosorbent Assay), VHH antibodies have rapidly become the preferred choice for both research and industrial diagnostic applications. Their single-domain architecture allows them to bind cryptic or recessed epitopes that are inaccessible to conventional antibodies, dramatically improving assay sensitivity and reducing background noise.
Furthermore, VHH antibodies can be genetically fused to detection tags (His-tag, Fc-fusion, biotin, HRP, etc.) or engineered into bispecific formats, enabling highly flexible ELISA platform design without compromising binding performance.
The compact single-domain structure of VHH enables access to epitopes hidden in protein grooves and active site clefts, dramatically lowering detection limits in sandwich and competitive ELISA formats.
VHH antibodies maintain structural integrity at temperatures exceeding 70°C and across a wide pH range (3–10), making them ideal for industrial diagnostic kits requiring long shelf life and harsh condition resilience.
Nanobodies are produced in microbial expression systems (E. coli, yeast) with high yield and batch-to-batch consistency — critical for commercial ELISA kit manufacturing at industrial scale.
VHH antibodies are easily fused with HRP, biotin, Fc regions, His-tags, or fluorescent proteins, enabling flexible ELISA detection architectures including direct, indirect, sandwich, and competitive formats.
The absence of light chains eliminates Fc-receptor mediated background binding, resulting in significantly lower noise-to-signal ratios and more accurate quantification in complex biological matrices.
Compared to conventional monoclonal antibody production, VHH manufacturing requires no mammalian cell culture infrastructure, reducing COGS by up to 60% for large-scale ELISA reagent supply chains.
VHH-based ELISA kits are increasingly adopted in IVD for biomarker detection in serum, plasma, and urine. Their ability to distinguish closely related protein isoforms makes them invaluable for cancer biomarker panels, cardiac troponin assays, and infectious disease serology. Regulatory-grade nanobody ELISA kits are now entering CE-IVD and FDA 510(k) submission pipelines globally.
Nanobody ELISA systems are widely deployed for rapid detection of aflatoxins, ochratoxin A, zearalenone, and other mycotoxins in grain, feed, and processed food. Their heat stability allows integration into lateral flow and microplate ELISA formats without cold-chain dependency — a major advantage for on-site testing in developing markets.
In biomanufacturing, VHH antibodies are used in process ELISA to monitor host cell protein (HCP) levels, residual protein A, and drug substance concentrations during upstream and downstream processing. Their high specificity minimizes cross-reactivity with complex manufacturing matrices, ensuring compliance with ICH Q6B guidelines.
VHH-ELISA platforms enable ultra-sensitive detection of pesticide residues, heavy metal-chelated proteins, endocrine disruptors, and emerging contaminants in water and soil samples. Their stability in harsh environmental matrices (high salinity, variable pH) outperforms conventional antibody-based assays in field-deployable testing scenarios.
In immunology research, VHH-based sandwich ELISA kits for cytokines (IL-6, TNF-α, IFN-γ) offer femtomolar sensitivity, enabling detection of low-abundance immune mediators in cell culture supernatants and tissue lysates. This is particularly critical for CAR-T cell therapy monitoring and tumor microenvironment characterization studies.
Anti-camelid VHH antibodies are used in competitive ELISA for veterinary pathogen surveillance, including avian influenza, foot-and-mouth disease virus, and African swine fever. Their camelid origin provides natural cross-reactivity advantages for detecting conserved viral epitopes across multiple animal species.
Succeed in 3000+ Projects
We have 800+ Clients
Produced 20000+ Products
Clients 75% Repeat Rate
Alpha Lifetech Inc. was founded by a group of scientists with extensive experience in membrane protein production, nanobody discovery, monoclonal development, and other pharmaceutical pre-development services. Based on our several technology service platforms, Alpha Lifetech Inc. has launched nearly 10,000 high-quality spot membrane protein reagents, cytokines, drug target antibodies and other related reagents.
Whether you're working in the fields of immunology, cell biology, molecular biology, or any other scientific discipline, Alpha Lifetech's comprehensive range of research products will help you achieve accurate and reliable results. We pride ourselves on being able to offer a comprehensive set of high-quality products and services tailored to customer needs, which help advance the projects of scientific research institutions, academics, and enterprises in the life science industry.
Alpha Lifetech Inc. is committed to providing the highest level of customer services, competitive pricing, speedy delivery, and a comprehensive, cutting-edge product offering. Our sales and technical support staff are available to help you select the right products and service solutions. As a reliable supplier and partner, Alpha Lifetech Inc. always puts customers first. We cherish every opportunity to collaborate with worldwide customers in scientific exploration. Welcome to contact our technical support at any time.
Our team of experienced scientists works closely with customers to design and execute tailored strategies for nanobody discovery, ensuring the generation of high-quality leads that align with project goals.
Antibody humanization from a broad range of parental species including mouse, rat, rabbit, llama, and avian.
Our Membrane Proteomics platform offers a comprehensive solution for the identification, quantification, and characterization of membrane proteins, providing valuable insights into their functions and interactions within the cell.
Alpha Lifetech can offer the native antibody libraries (scFv, Fab, VHH Formats and customized) from host animals like Goat, Camel and Llama.
Our platform utilizes phage and yeast display technology to develop different forms of antibodies: VHH single domain antibodies, Fab antibodies, and scFv antibodies, resulting in high affinity and high specificity antibodies — perfectly suited for ELISA capture and detection reagent development.
READ MORE
We also provide a series of technical services related to antibody engineering, stable cell line construction, yeast display, protein interaction analysis, etc., laying the foundation for antibody development and ELISA reagent production.
READ MORE
Our monoclonal antibody development services include three technologies: phage display technology, single-B cell technology, and hybridoma cell technology, which produce monoclonal antibodies for different species — enabling comprehensive ELISA pair screening and validation.
READ MORE
The aptamer platform provided by Alpha Lifetech includes two categories: aptamer synthesis platform, which mainly involves SELEX aptamer library synthesis service and aptamer development service, and aptamer screening platform including screening services based on SELEX technology for proteins, peptides, cells, small molecules, and other target molecules, as well as aptamer optimization and identification analysis services.
READ MORE"Exceptional Nanobody discovery capabilities from Alpha Lifetech. Their team's dedication to customer satisfaction and scientific excellence is evident in every interaction. Grateful for their partnership and looking forward to future collaborations!"
— Riley Harper"Quality products! Our experience with Alpha Lifetech has been nothing short of outstanding. Simply put, Alpha Lifetech delivers. Their dedication to customer satisfaction and quality service is unmatched, and we're grateful to have them as a trusted partner."
— Ava Mitchell & Stella Grant"Reliable, responsive, and results-driven — Alpha Lifetech. Their VHH antibody products for ELISA have consistently delivered superior sensitivity and specificity in our diagnostic assay development workflows."
— Olivia West
